News About: Pharm. Industry
Boehringer Ingelheim's Trajenta ranked no.1. among the outpatient prescription cost of DPP-4 family drugs
According to the outpatient prescription cost of DPP-4 family drugs in the first half of 2014 based on Ubist data, it was identified that Boehringer Ingelheim's Trajenta ranked no.1. Trajenta used sales capacity of Yu...
The number of employees in major pharmaceutical companies increased slightly compare to the same period last year
At the end-March this year, the number of employees in major pharmaceutical companies increased slightly compare to the same period last year. However, it was estimated that this figure is still less than the level of...
Crystal Genomics identified that 'Polmacoxib' has effect for preventing and curing colon cancer
New drug development bio-venture company, Crystal Genomics identified that their new degenerative arthritis treatment 'Polmacoxib' of which they applied new drug application (NDA) in May, has effect for preventing and...
Conflict between KRPIA and KPA appeared with the implementation of Social Relief Scheme for Serious Adverse Drug Reactions ahead
With the implementation of Social Relief Scheme for Serious Adverse Drug Reactions ahead, conflict between pharmaceutical society is continuing on the problem of alloted charge.
Social Relief Scheme for Serious Adver...
Donga ST announced that they received sales approval of Sivextro in the United States followed by South Korea, Europe
Recently, Donga ST announced that they received sales approval of superbacteria target antibiotic Sivextro in the United States followed by South Korea, Europe, Canada, Japan, and China.
Three companies, including Do...
On August 20, KPWA hold a public forum with the theme of 'Are the distribution costs of pharmaceutical companies okay anyway?
On August 20, the Korea Pharmaceutical Wholesaler Association (KPWA) hold a public forum with the theme of 'Are the distribution costs of pharmaceutical companies okay anyway?'
In the forum, the result of study for p...
Celgene Korea received sales approval of multiple myeloma treatment 'Pomalyst'
On August 4, Celgene Korea, a global pharmaceutical company specializing in cancer areas received sales approval of multiple myeloma treatment 'Pomalyst (ingredient pomalidomide)' from the Ministry of Food and Drug Sa...
It was identified that public advertising expenses of pharmaceutical companies showed negative growth compared to the same period last year
According to the compiled result of 'Public advertising status of pharmaceutical company in the first half of 2014' based on 'Monthly advertising trends' (source Nielsen Korea) of Korea Federation of Advertising Assoc...
Most of domestic companies are in the process of clinical trial of quadrivalent vaccines, and only GSK requested sales of quadrivalent vaccine 'Fluarix'
Recently, people are paying attention to whether quadrivalent influenza vaccine will be released in this season or not, because WHO's prediction about endemic influenza virus often turned out to be wrong.
Currently, ...
Alvogen announced to acquire Dream Pharma with 194.5 billion won in cash through its subsidiary Kunwha Pharmaceutical
Alvogen announced that they confirmed to acquire Dream Pharma with 194.5 billion won in cash through its subsidiary company Kunwha Pharmaceutical. The official procedure is expected to be completed in the fourth quart...
